About Immix Biopharma, Inc. 
Immix Biopharma, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 7 Schemes (9.97%)
Foreign Institutions
Held by 13 Foreign Institutions (7.11%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-10 Million
Pharmaceuticals & Biotechnology
USD 432 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.07
-31.39%
4.61






